Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. It is given by slow injection into a vein. Common side effects include fatigue, musculoskeletal pain, decreased appetite, itchy skin (pruritus), diarrhea,... [wikipedia]1 Discussion
Related BrandsDrugs with the same active ingredients
Pembrolizumab and Glutathione
My husband is in immunotherapy, undergoing 1 infusion of pembrolizumab ('Keytruda') every three weeks. Is it hel...